At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4 enrolled
Drug / intervention
Enlighten™ Laser and a MLA Attachmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Open-label, Prospective, Multicenter Study to Evaluate the Cutera Enlighten™ Laser and a Micro-Lens Array Handpiece Attachment for the Treatment of Moderate to Severe Acne Scars
In Brief
A clinical study evaluating Enlighten™ Laser and a MLA Attachment for Scarring and Acne. Completed, enrolled 4 participants across 1 site.
Detailed Summary
The purpose of this pivotal investigation is to evaluate the efficacy and safety of the Cutera enlighten multi-wavelength 532 nm and 1064 nm picosecond pulse duration laser and an investigational micro-lens array (MLA) handpiece attachment for improvement of moderate to severe acne scars.
Study Details
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartAug 2017
First PostedFeb 2018
Primary CompletionMay 2018
TodayJul 2026
First PostedFeb 13, 2018
Enrollment StartAug 15, 2017
Primary CompletionMay 30, 2018
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 8.4 years ago
Interventions
Enlighten™ Laser and a MLA Attachmentdevice
Subjects will receive treatments with the Cutera enlighten laser with the Micro-Lens Array handpiece attachment.